Anna Laurell

Phase III Study to Evaluate Temsirolimus Compared With Investigator's Choice Therapy for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

Raoul Herbrecht, Jorge Romaguera, Gregor Verhoef et al. · Journal of Clinical Oncology · 2009 · 640 citations

Pharmacy, Oncology, Pharmacotherapy +11

Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo–purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group

Christian H. Geisler, Arne Kolstad, Anna Laurell et al. · Blood · 2008 · 624 citations · Full text

Medicine, Hematology, Oncology +13

Nordic <scp>MCL</scp>2 trial update: six‐year follow‐up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by <scp>BEAM</scp> or <scp>BEAC</scp> + autologous stem‐cell support: still very long survival but late relapses do occur

Christian H. Geisler, Arne Kolstad, Anna Laurell et al. · British Journal of Haematology · 2012 · 272 citations

Medicine, Immunology, Oncology +13

Risk-Adapted Treatment in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: The SWENOTECA Management Program

Torgrim Tandstad, Olav Dahl, Gabriella Cohn‐Cedermark et al. · Journal of Clinical Oncology · 2009 · 266 citations · Full text

Medicine, Oncology, Cancer Control +15

Management of Seminomatous Testicular Cancer: A Binational Prospective Population-Based Study From the Swedish Norwegian Testicular Cancer Study Group

Torgrim Tandstad, Rune Smaaland, Arne Solberg et al. · Journal of Clinical Oncology · 2011 · 230 citations · Full text

Medicine, Oncology, Chemotherapy +15